Oncologists classify breast cancer tissue based on its levels of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor-2 expressions in biopsy specimens, and use that information to classify breast cancers into categories of triple-negative breast cancer, luminal breast cancer, and HER2+ breast cancer [2]. This evidence concerns the gene PGR and breast carcinoma.